| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prenatal Diagnosis | 39 | 2025 | 1271 | 5.330 |
Why?
|
| Fetal Diseases | 24 | 2024 | 915 | 3.170 |
Why?
|
| Aneuploidy | 17 | 2023 | 573 | 2.660 |
Why?
|
| Hypoplastic Left Heart Syndrome | 18 | 2020 | 595 | 1.920 |
Why?
|
| Pregnancy | 139 | 2025 | 30238 | 1.860 |
Why?
|
| Ultrasonography, Prenatal | 40 | 2020 | 1772 | 1.770 |
Why?
|
| Aortic Valve Stenosis | 21 | 2022 | 2021 | 1.710 |
Why?
|
| Down Syndrome | 8 | 2020 | 916 | 1.650 |
Why?
|
| Chromosome Aberrations | 9 | 2020 | 1776 | 1.540 |
Why?
|
| Fetal Therapies | 12 | 2020 | 101 | 1.530 |
Why?
|
| Fetal Heart | 15 | 2024 | 281 | 1.430 |
Why?
|
| Genetic Testing | 18 | 2025 | 3591 | 1.400 |
Why?
|
| Congenital Abnormalities | 8 | 2020 | 703 | 1.380 |
Why?
|
| Genetic Diseases, Inborn | 6 | 2023 | 606 | 1.360 |
Why?
|
| Pregnancy Outcome | 26 | 2022 | 2972 | 1.240 |
Why?
|
| Chromosome Disorders | 9 | 2021 | 498 | 1.150 |
Why?
|
| Prenatal Care | 16 | 2023 | 1158 | 1.050 |
Why?
|
| Hypertension, Pregnancy-Induced | 3 | 2024 | 529 | 1.030 |
Why?
|
| Preimplantation Diagnosis | 3 | 2022 | 143 | 0.970 |
Why?
|
| Obstetrics | 6 | 2023 | 679 | 0.940 |
Why?
|
| Pre-Eclampsia | 8 | 2021 | 1255 | 0.940 |
Why?
|
| Reproductive Techniques, Assisted | 6 | 2015 | 503 | 0.890 |
Why?
|
| Gestational Age | 32 | 2021 | 3618 | 0.890 |
Why?
|
| Fetal Growth Retardation | 6 | 2015 | 592 | 0.840 |
Why?
|
| Pregnancy Complications | 18 | 2015 | 2971 | 0.830 |
Why?
|
| Mosaicism | 6 | 2017 | 480 | 0.800 |
Why?
|
| Sex Chromosome Aberrations | 3 | 2022 | 116 | 0.790 |
Why?
|
| Stillbirth | 5 | 2020 | 381 | 0.790 |
Why?
|
| Karyotyping | 11 | 2022 | 1176 | 0.760 |
Why?
|
| Amniocentesis | 2 | 2018 | 116 | 0.730 |
Why?
|
| Fertilization in Vitro | 7 | 2022 | 1303 | 0.700 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 2020 | 46 | 0.690 |
Why?
|
| Societies | 1 | 2020 | 106 | 0.690 |
Why?
|
| Channelopathies | 1 | 2020 | 32 | 0.680 |
Why?
|
| Postpartum Period | 3 | 2024 | 1198 | 0.670 |
Why?
|
| Nuchal Translucency Measurement | 4 | 2023 | 59 | 0.660 |
Why?
|
| Maternal-Fetal Exchange | 3 | 2020 | 454 | 0.650 |
Why?
|
| Catheterization | 10 | 2011 | 1430 | 0.640 |
Why?
|
| Hernia, Umbilical | 3 | 2009 | 102 | 0.610 |
Why?
|
| Alcohol Drinking | 12 | 2011 | 4045 | 0.600 |
Why?
|
| Pregnancy Trimester, First | 6 | 2016 | 917 | 0.600 |
Why?
|
| Vein of Galen Malformations | 3 | 2023 | 57 | 0.590 |
Why?
|
| Pregnancy Proteins | 3 | 2015 | 222 | 0.570 |
Why?
|
| Genomic Imprinting | 3 | 2015 | 326 | 0.570 |
Why?
|
| Female | 146 | 2025 | 396660 | 0.560 |
Why?
|
| 22q11 Deletion Syndrome | 1 | 2017 | 18 | 0.560 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 3 | 2015 | 559 | 0.550 |
Why?
|
| Heart Defects, Congenital | 13 | 2024 | 4713 | 0.550 |
Why?
|
| Sex Chromosomes | 3 | 2023 | 101 | 0.550 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 2 | 2014 | 60 | 0.540 |
Why?
|
| Cordocentesis | 1 | 2016 | 10 | 0.530 |
Why?
|
| Gynecology | 5 | 2023 | 534 | 0.520 |
Why?
|
| Pulmonary Atresia | 2 | 2014 | 159 | 0.490 |
Why?
|
| Spouses | 3 | 2006 | 286 | 0.470 |
Why?
|
| Troponin | 1 | 2018 | 536 | 0.450 |
Why?
|
| Reproductive History | 1 | 2015 | 210 | 0.450 |
Why?
|
| alpha-Fetoproteins | 4 | 1998 | 229 | 0.450 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2014 | 83 | 0.450 |
Why?
|
| Fetus | 9 | 2023 | 1878 | 0.440 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2015 | 361 | 0.440 |
Why?
|
| Beckwith-Wiedemann Syndrome | 3 | 2009 | 45 | 0.430 |
Why?
|
| DNA | 9 | 2016 | 7210 | 0.420 |
Why?
|
| Placenta | 4 | 2017 | 1726 | 0.420 |
Why?
|
| Cardiology | 1 | 2024 | 1701 | 0.420 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2015 | 474 | 0.410 |
Why?
|
| Humans | 155 | 2025 | 767040 | 0.410 |
Why?
|
| Patient Transfer | 1 | 2019 | 788 | 0.400 |
Why?
|
| Infant, Newborn | 37 | 2023 | 26396 | 0.400 |
Why?
|
| Twins | 2 | 2011 | 341 | 0.390 |
Why?
|
| Diagnostic Errors | 3 | 2017 | 1278 | 0.380 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2017 | 788 | 0.380 |
Why?
|
| Pregnancy, High-Risk | 2 | 2018 | 121 | 0.380 |
Why?
|
| Chromosome Deletion | 2 | 2015 | 1384 | 0.380 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2014 | 468 | 0.370 |
Why?
|
| Genetic Counseling | 4 | 2021 | 635 | 0.360 |
Why?
|
| Pregnancy, Multiple | 2 | 2011 | 216 | 0.350 |
Why?
|
| Term Birth | 3 | 2016 | 140 | 0.350 |
Why?
|
| Toluene | 3 | 1997 | 34 | 0.350 |
Why?
|
| Ventricular Remodeling | 1 | 2018 | 1281 | 0.340 |
Why?
|
| Hydrops Fetalis | 3 | 2016 | 113 | 0.340 |
Why?
|
| DiGeorge Syndrome | 2 | 2023 | 187 | 0.340 |
Why?
|
| Temperance | 2 | 2006 | 88 | 0.330 |
Why?
|
| Pregnancy in Adolescence | 1 | 2011 | 166 | 0.330 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2018 | 1749 | 0.320 |
Why?
|
| Societies, Medical | 2 | 2020 | 3964 | 0.310 |
Why?
|
| Psychotherapy, Brief | 2 | 2006 | 118 | 0.310 |
Why?
|
| Echocardiography, Doppler | 4 | 2014 | 898 | 0.300 |
Why?
|
| Population Surveillance | 3 | 2015 | 2594 | 0.300 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2015 | 4054 | 0.290 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 1368 | 0.290 |
Why?
|
| Adult | 60 | 2025 | 223317 | 0.290 |
Why?
|
| Alcoholism | 7 | 2011 | 1980 | 0.290 |
Why?
|
| Placenta Diseases | 4 | 2015 | 199 | 0.270 |
Why?
|
| Atrial Septum | 3 | 2017 | 61 | 0.270 |
Why?
|
| Ductus Arteriosus | 2 | 2020 | 42 | 0.260 |
Why?
|
| Retrospective Studies | 33 | 2025 | 81659 | 0.260 |
Why?
|
| Neck | 1 | 2011 | 736 | 0.260 |
Why?
|
| Decidua | 1 | 2006 | 82 | 0.260 |
Why?
|
| Peptide Fragments | 1 | 2018 | 5141 | 0.240 |
Why?
|
| Cannabis | 1 | 2011 | 447 | 0.240 |
Why?
|
| Delivery, Obstetric | 4 | 2014 | 949 | 0.230 |
Why?
|
| Trophoblasts | 1 | 2006 | 223 | 0.230 |
Why?
|
| Overweight | 1 | 2015 | 2448 | 0.220 |
Why?
|
| Postnatal Care | 2 | 2024 | 273 | 0.220 |
Why?
|
| Diabetes, Gestational | 3 | 2021 | 1263 | 0.220 |
Why?
|
| Puerperal Disorders | 2 | 2024 | 304 | 0.220 |
Why?
|
| Fathers | 1 | 2006 | 377 | 0.210 |
Why?
|
| Communication | 1 | 2017 | 3904 | 0.210 |
Why?
|
| Embolization, Therapeutic | 2 | 2023 | 1403 | 0.210 |
Why?
|
| Mass Screening | 6 | 2017 | 5456 | 0.200 |
Why?
|
| Heart Septal Defects, Atrial | 3 | 2014 | 452 | 0.200 |
Why?
|
| Amniotic Fluid | 2 | 2018 | 381 | 0.200 |
Why?
|
| Internal Medicine | 2 | 2023 | 1064 | 0.200 |
Why?
|
| Genes, Dominant | 1 | 2025 | 855 | 0.200 |
Why?
|
| Galactosemias | 1 | 2023 | 126 | 0.190 |
Why?
|
| Cerebral Veins | 1 | 2023 | 157 | 0.190 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 2015 | 2509 | 0.190 |
Why?
|
| Diseases in Twins | 3 | 2015 | 447 | 0.190 |
Why?
|
| Epigenesis, Genetic | 3 | 2015 | 3828 | 0.190 |
Why?
|
| Body Mass Index | 3 | 2021 | 13048 | 0.190 |
Why?
|
| Goals | 1 | 2006 | 717 | 0.180 |
Why?
|
| Chorion | 4 | 2015 | 113 | 0.180 |
Why?
|
| Abortion, Induced | 2 | 2017 | 471 | 0.180 |
Why?
|
| Pandemics | 1 | 2020 | 8736 | 0.180 |
Why?
|
| Behavior Therapy | 1 | 2006 | 886 | 0.180 |
Why?
|
| Embryo Transfer | 2 | 2022 | 527 | 0.180 |
Why?
|
| Infertility | 2 | 2023 | 655 | 0.170 |
Why?
|
| Semen | 1 | 2023 | 349 | 0.170 |
Why?
|
| Blood Circulation | 1 | 2021 | 248 | 0.170 |
Why?
|
| Self Report | 1 | 2011 | 3773 | 0.170 |
Why?
|
| Ebstein Anomaly | 1 | 2020 | 106 | 0.170 |
Why?
|
| General Practitioners | 1 | 2021 | 103 | 0.160 |
Why?
|
| Trisomy | 2 | 2016 | 260 | 0.160 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2020 | 140 | 0.160 |
Why?
|
| Hernia, Diaphragmatic | 2 | 2012 | 244 | 0.160 |
Why?
|
| Substance-Related Disorders | 3 | 2011 | 4422 | 0.160 |
Why?
|
| Fetal Blood | 3 | 2023 | 1361 | 0.150 |
Why?
|
| Fetoscopy | 2 | 2009 | 140 | 0.150 |
Why?
|
| Decision Trees | 1 | 2020 | 508 | 0.150 |
Why?
|
| Neural Tube Defects | 2 | 1999 | 255 | 0.150 |
Why?
|
| Hemodynamics | 5 | 2022 | 4186 | 0.150 |
Why?
|
| Monosomy | 1 | 2017 | 52 | 0.150 |
Why?
|
| Maternal Age | 5 | 2010 | 804 | 0.150 |
Why?
|
| Tricuspid Valve | 1 | 2020 | 419 | 0.140 |
Why?
|
| Embryo, Mammalian | 2 | 2021 | 1676 | 0.140 |
Why?
|
| Vascular Malformations | 1 | 2023 | 469 | 0.140 |
Why?
|
| Genetics, Medical | 1 | 2000 | 334 | 0.140 |
Why?
|
| Oligospermia | 1 | 1997 | 59 | 0.140 |
Why?
|
| Cell-Free System | 2 | 2016 | 339 | 0.140 |
Why?
|
| Hypogonadism | 1 | 2023 | 805 | 0.130 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2020 | 361 | 0.130 |
Why?
|
| Teratogens | 1 | 1997 | 119 | 0.130 |
Why?
|
| Microinjections | 1 | 1997 | 319 | 0.130 |
Why?
|
| Rh Isoimmunization | 1 | 2016 | 23 | 0.130 |
Why?
|
| Physicians, Primary Care | 1 | 2023 | 623 | 0.130 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2021 | 519 | 0.130 |
Why?
|
| Birth Weight | 3 | 2014 | 2122 | 0.130 |
Why?
|
| Abnormalities, Multiple | 4 | 2013 | 1424 | 0.130 |
Why?
|
| Choice Behavior | 2 | 2016 | 848 | 0.130 |
Why?
|
| Patient Education as Topic | 2 | 2006 | 2337 | 0.130 |
Why?
|
| Face | 3 | 2001 | 1029 | 0.130 |
Why?
|
| Indomethacin | 2 | 2020 | 323 | 0.120 |
Why?
|
| Triploidy | 1 | 2014 | 3 | 0.120 |
Why?
|
| Fetal Resorption | 1 | 2014 | 15 | 0.120 |
Why?
|
| Sensitivity and Specificity | 7 | 2018 | 14672 | 0.120 |
Why?
|
| Abnormalities, Drug-Induced | 2 | 1997 | 337 | 0.120 |
Why?
|
| False Positive Reactions | 2 | 2015 | 959 | 0.120 |
Why?
|
| Coronary Circulation | 2 | 2018 | 1603 | 0.120 |
Why?
|
| Polycystic Kidney, Autosomal Recessive | 1 | 2014 | 31 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2021 | 4859 | 0.120 |
Why?
|
| Ovary | 2 | 2023 | 965 | 0.120 |
Why?
|
| Vascular Diseases | 1 | 2023 | 1161 | 0.120 |
Why?
|
| Fertilization | 1 | 2015 | 197 | 0.120 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2014 | 41 | 0.110 |
Why?
|
| Pregnancy Trimester, Second | 4 | 2013 | 737 | 0.110 |
Why?
|
| Adolescent | 12 | 2019 | 89046 | 0.110 |
Why?
|
| Nucleotides | 1 | 2016 | 454 | 0.110 |
Why?
|
| Nasal Bone | 1 | 2013 | 58 | 0.110 |
Why?
|
| Cesarean Section | 4 | 2014 | 1419 | 0.110 |
Why?
|
| Predictive Value of Tests | 9 | 2021 | 15424 | 0.110 |
Why?
|
| Amnion | 2 | 2011 | 204 | 0.110 |
Why?
|
| Pleural Effusion | 1 | 1997 | 344 | 0.110 |
Why?
|
| Phenotype | 5 | 2021 | 16718 | 0.110 |
Why?
|
| Obesity | 2 | 2015 | 13085 | 0.110 |
Why?
|
| Attitude of Health Personnel | 2 | 2013 | 3928 | 0.110 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 15645 | 0.110 |
Why?
|
| Ambulatory Care Facilities | 1 | 2019 | 939 | 0.110 |
Why?
|
| Young Adult | 9 | 2019 | 59980 | 0.110 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2012 | 1481 | 0.110 |
Why?
|
| Program Development | 1 | 2019 | 1298 | 0.110 |
Why?
|
| Risk Factors | 16 | 2021 | 74886 | 0.110 |
Why?
|
| Spermatozoa | 1 | 1997 | 625 | 0.100 |
Why?
|
| Qualitative Research | 1 | 2024 | 3139 | 0.100 |
Why?
|
| CHARGE Syndrome | 1 | 2012 | 34 | 0.100 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 1422 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3797 | 0.100 |
Why?
|
| Genomic Library | 1 | 2012 | 189 | 0.100 |
Why?
|
| Hydatidiform Mole | 1 | 2014 | 255 | 0.100 |
Why?
|
| Statistics, Nonparametric | 4 | 2013 | 2850 | 0.100 |
Why?
|
| Stem Cell Transplantation | 1 | 2020 | 1596 | 0.100 |
Why?
|
| Patient Care Team | 1 | 2023 | 2516 | 0.100 |
Why?
|
| Lactation | 1 | 2014 | 392 | 0.090 |
Why?
|
| Anencephaly | 1 | 1991 | 20 | 0.090 |
Why?
|
| Medical History Taking | 1 | 2015 | 779 | 0.090 |
Why?
|
| Gene Rearrangement | 1 | 2016 | 1141 | 0.090 |
Why?
|
| Fetal Death | 4 | 2004 | 434 | 0.090 |
Why?
|
| International Cooperation | 2 | 2015 | 1434 | 0.090 |
Why?
|
| Hepatitis B | 1 | 1996 | 710 | 0.090 |
Why?
|
| Treatment Outcome | 20 | 2022 | 65295 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2270 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2018 | 3667 | 0.090 |
Why?
|
| Male | 31 | 2023 | 364203 | 0.090 |
Why?
|
| Infant, Low Birth Weight | 1 | 2015 | 871 | 0.090 |
Why?
|
| Case-Control Studies | 7 | 2015 | 22254 | 0.090 |
Why?
|
| Chorionic Villi | 3 | 1995 | 53 | 0.090 |
Why?
|
| Endocardial Fibroelastosis | 1 | 2010 | 66 | 0.090 |
Why?
|
| Cytogenetic Analysis | 1 | 2011 | 270 | 0.090 |
Why?
|
| Fetofetal Transfusion | 3 | 2015 | 119 | 0.090 |
Why?
|
| CpG Islands | 1 | 2015 | 1206 | 0.090 |
Why?
|
| Tocolytic Agents | 1 | 2009 | 24 | 0.090 |
Why?
|
| Patient Readmission | 1 | 2024 | 3283 | 0.080 |
Why?
|
| Antihypertensive Agents | 1 | 2019 | 2030 | 0.080 |
Why?
|
| Microcephaly | 1 | 1994 | 426 | 0.080 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2009 | 353 | 0.080 |
Why?
|
| Video-Assisted Surgery | 1 | 2009 | 51 | 0.080 |
Why?
|
| Ultrasonography, Doppler | 3 | 2020 | 463 | 0.080 |
Why?
|
| Gametogenesis | 1 | 2009 | 27 | 0.080 |
Why?
|
| Optical Phenomena | 1 | 2009 | 103 | 0.080 |
Why?
|
| Comorbidity | 2 | 2017 | 10582 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2018 | 6067 | 0.080 |
Why?
|
| Parents | 1 | 2022 | 3594 | 0.080 |
Why?
|
| Lipids | 2 | 2021 | 3322 | 0.080 |
Why?
|
| Twins, Monozygotic | 1 | 2010 | 471 | 0.080 |
Why?
|
| Ultrasonography, Interventional | 2 | 2023 | 1523 | 0.080 |
Why?
|
| Massachusetts | 3 | 2013 | 8890 | 0.080 |
Why?
|
| Aortic Valve | 3 | 2009 | 1968 | 0.070 |
Why?
|
| Risk | 2 | 2017 | 9606 | 0.070 |
Why?
|
| Follow-Up Studies | 11 | 2014 | 39317 | 0.070 |
Why?
|
| Ventricular Function | 1 | 2009 | 404 | 0.070 |
Why?
|
| Heart Septum | 1 | 2008 | 304 | 0.070 |
Why?
|
| Obstetric Labor, Premature | 2 | 2010 | 268 | 0.070 |
Why?
|
| Chi-Square Distribution | 2 | 2006 | 3431 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2017 | 3683 | 0.070 |
Why?
|
| Infant, Premature | 3 | 2004 | 2125 | 0.070 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2007 | 42 | 0.070 |
Why?
|
| Social Facilitation | 1 | 2006 | 31 | 0.070 |
Why?
|
| Recurrence | 1 | 2019 | 8504 | 0.070 |
Why?
|
| Risk Assessment | 10 | 2020 | 24299 | 0.070 |
Why?
|
| Prospective Studies | 5 | 2022 | 54886 | 0.070 |
Why?
|
| Primary Health Care | 1 | 2023 | 4746 | 0.070 |
Why?
|
| Boston | 3 | 2017 | 9360 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2021 | 6611 | 0.060 |
Why?
|
| Perinatal Mortality | 2 | 2020 | 103 | 0.060 |
Why?
|
| Reference Values | 3 | 2006 | 4918 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 1999 | 2538 | 0.060 |
Why?
|
| Live Birth | 2 | 2020 | 516 | 0.060 |
Why?
|
| Perinatology | 1 | 2005 | 64 | 0.060 |
Why?
|
| Twinning, Monozygotic | 2 | 2015 | 17 | 0.060 |
Why?
|
| Hypertension | 2 | 2023 | 8615 | 0.060 |
Why?
|
| Habits | 1 | 2006 | 148 | 0.060 |
Why?
|
| Blood Glucose | 2 | 2021 | 6421 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 1994 | 1518 | 0.060 |
Why?
|
| Thoracotomy | 1 | 2007 | 374 | 0.060 |
Why?
|
| Nurse-Patient Relations | 1 | 2005 | 101 | 0.060 |
Why?
|
| Cohort Studies | 7 | 2021 | 41718 | 0.060 |
Why?
|
| Infarction | 1 | 2006 | 247 | 0.060 |
Why?
|
| Heart Atria | 1 | 2011 | 1362 | 0.060 |
Why?
|
| Drug Tolerance | 1 | 2006 | 365 | 0.060 |
Why?
|
| Probability | 3 | 2023 | 2476 | 0.060 |
Why?
|
| ROC Curve | 3 | 2010 | 3618 | 0.060 |
Why?
|
| Family | 1 | 2015 | 3210 | 0.060 |
Why?
|
| Echocardiography | 2 | 2020 | 5042 | 0.060 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2006 | 291 | 0.050 |
Why?
|
| Lymphatic System | 1 | 2005 | 250 | 0.050 |
Why?
|
| Maternal Behavior | 1 | 2006 | 307 | 0.050 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2004 | 137 | 0.050 |
Why?
|
| Pilot Projects | 3 | 2012 | 8732 | 0.050 |
Why?
|
| Infant, Premature, Diseases | 1 | 2009 | 712 | 0.050 |
Why?
|
| HELLP Syndrome | 2 | 2006 | 41 | 0.050 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2011 | 2144 | 0.050 |
Why?
|
| Time Factors | 5 | 2020 | 40154 | 0.050 |
Why?
|
| Teratoma | 1 | 2005 | 405 | 0.050 |
Why?
|
| Stents | 1 | 2014 | 3193 | 0.050 |
Why?
|
| Ethics Committees, Research | 1 | 2023 | 196 | 0.050 |
Why?
|
| Middle Cerebral Artery | 2 | 2015 | 271 | 0.050 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2001 | 111 | 0.050 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2011 | 1414 | 0.050 |
Why?
|
| Logistic Models | 3 | 2021 | 13284 | 0.050 |
Why?
|
| Constriction | 1 | 2020 | 168 | 0.050 |
Why?
|
| Ultrasonography | 4 | 2023 | 6000 | 0.040 |
Why?
|
| Twins, Conjoined | 1 | 2000 | 41 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2015 | 4426 | 0.040 |
Why?
|
| Infant | 6 | 2023 | 36485 | 0.040 |
Why?
|
| Gene Expression | 1 | 1993 | 7587 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2001 | 313 | 0.040 |
Why?
|
| Risk-Taking | 1 | 2005 | 1023 | 0.040 |
Why?
|
| Airway Obstruction | 1 | 2005 | 672 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2010 | 2672 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2015 | 8531 | 0.040 |
Why?
|
| Dystocia | 1 | 1999 | 33 | 0.040 |
Why?
|
| Vinblastine | 1 | 2001 | 482 | 0.040 |
Why?
|
| Fatty Liver | 1 | 2006 | 811 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2001 | 534 | 0.040 |
Why?
|
| Middle Aged | 8 | 2019 | 223233 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2022 | 751 | 0.040 |
Why?
|
| Mutation | 4 | 2012 | 30211 | 0.040 |
Why?
|
| Ibuprofen | 1 | 2020 | 228 | 0.040 |
Why?
|
| Health Education | 1 | 2006 | 1058 | 0.040 |
Why?
|
| Models, Animal | 1 | 2005 | 2121 | 0.040 |
Why?
|
| Registries | 1 | 2015 | 8351 | 0.040 |
Why?
|
| Translocation, Genetic | 2 | 2016 | 1391 | 0.040 |
Why?
|
| Cervical Vertebrae | 1 | 2005 | 978 | 0.040 |
Why?
|
| Co-Repressor Proteins | 1 | 2019 | 190 | 0.040 |
Why?
|
| Chorionic Villi Sampling | 2 | 2001 | 35 | 0.040 |
Why?
|
| Heart Failure | 1 | 2023 | 11877 | 0.040 |
Why?
|
| Spinal Neoplasms | 1 | 2005 | 714 | 0.040 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2001 | 260 | 0.040 |
Why?
|
| Maternal Exposure | 1 | 2006 | 1096 | 0.040 |
Why?
|
| Abdominal Muscles | 1 | 1999 | 172 | 0.040 |
Why?
|
| Self Disclosure | 1 | 1999 | 248 | 0.040 |
Why?
|
| Lung | 1 | 2017 | 10076 | 0.040 |
Why?
|
| Fertility | 1 | 2023 | 771 | 0.040 |
Why?
|
| Genome, Human | 3 | 2016 | 4441 | 0.040 |
Why?
|
| Reproducibility of Results | 6 | 2013 | 20169 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 14766 | 0.040 |
Why?
|
| Income | 1 | 2006 | 1877 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2009 | 3837 | 0.030 |
Why?
|
| Counseling | 1 | 2005 | 1553 | 0.030 |
Why?
|
| Estriol | 1 | 1996 | 53 | 0.030 |
Why?
|
| Central Nervous System Depressants | 1 | 1998 | 163 | 0.030 |
Why?
|
| Acidosis, Renal Tubular | 1 | 1997 | 50 | 0.030 |
Why?
|
| Obstetric Labor Complications | 1 | 1999 | 240 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2021 | 646 | 0.030 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 377 | 0.030 |
Why?
|
| Chromosome Mapping | 2 | 2016 | 4616 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2005 | 6215 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2024 | 2741 | 0.030 |
Why?
|
| Growth Disorders | 1 | 2001 | 635 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2015 | 26325 | 0.030 |
Why?
|
| Premature Birth | 1 | 2009 | 1830 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2013 | 587 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2017 | 15824 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2016 | 145 | 0.030 |
Why?
|
| Social Support | 1 | 2006 | 2192 | 0.030 |
Why?
|
| Suction | 1 | 1997 | 268 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2016 | 192 | 0.030 |
Why?
|
| DNA Probes | 1 | 1996 | 541 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2016 | 247 | 0.030 |
Why?
|
| Paraffin Embedding | 1 | 1996 | 303 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2023 | 8048 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1996 | 294 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2007 | 2726 | 0.030 |
Why?
|
| Incidence | 3 | 2013 | 21526 | 0.030 |
Why?
|
| Child, Preschool | 5 | 2020 | 42606 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 16036 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2016 | 570 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 4780 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2005 | 2697 | 0.030 |
Why?
|
| Fasting | 1 | 2021 | 1607 | 0.030 |
Why?
|
| Parity | 2 | 2010 | 931 | 0.030 |
Why?
|
| Chorionic Gonadotropin | 1 | 1996 | 458 | 0.030 |
Why?
|
| Health Behavior | 1 | 2006 | 2650 | 0.030 |
Why?
|
| Ploidies | 1 | 1995 | 287 | 0.030 |
Why?
|
| Polycythemia | 1 | 2015 | 124 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 1997 | 1154 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 1999 | 903 | 0.030 |
Why?
|
| Educational Status | 1 | 2021 | 2511 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2021 | 2428 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 1996 | 1181 | 0.030 |
Why?
|
| Barotrauma | 1 | 2012 | 41 | 0.030 |
Why?
|
| Nutritional Requirements | 1 | 2014 | 279 | 0.030 |
Why?
|
| Cytoplasm | 1 | 1997 | 1504 | 0.030 |
Why?
|
| Thrombosis | 1 | 2006 | 2954 | 0.020 |
Why?
|
| Specimen Handling | 1 | 1996 | 706 | 0.020 |
Why?
|
| Fragile X Syndrome | 1 | 1993 | 116 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 12069 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2019 | 1188 | 0.020 |
Why?
|
| Ethanol | 1 | 1998 | 1330 | 0.020 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2014 | 267 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2013 | 562 | 0.020 |
Why?
|
| Animals | 6 | 2023 | 168965 | 0.020 |
Why?
|
| Lung Volume Measurements | 1 | 2012 | 381 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 12250 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2022 | 5311 | 0.020 |
Why?
|
| Women's Health | 1 | 2000 | 2082 | 0.020 |
Why?
|
| Child | 5 | 2020 | 80771 | 0.020 |
Why?
|
| Edema | 1 | 1995 | 764 | 0.020 |
Why?
|
| Gene Deletion | 2 | 2001 | 2668 | 0.020 |
Why?
|
| Primates | 1 | 1993 | 519 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 1993 | 624 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2015 | 698 | 0.020 |
Why?
|
| Disease Progression | 2 | 2020 | 13646 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2015 | 829 | 0.020 |
Why?
|
| Mesoderm | 1 | 1993 | 679 | 0.020 |
Why?
|
| Umbilical Arteries | 1 | 2010 | 77 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2020 | 2978 | 0.020 |
Why?
|
| Surgical Mesh | 1 | 2012 | 315 | 0.020 |
Why?
|
| Parenteral Nutrition | 1 | 2014 | 663 | 0.020 |
Why?
|
| Expert Testimony | 1 | 2011 | 266 | 0.020 |
Why?
|
| Administration, Oral | 1 | 1997 | 4026 | 0.020 |
Why?
|
| Diastole | 1 | 2011 | 784 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 29963 | 0.020 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2014 | 587 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2023 | 36582 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2009 | 443 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2013 | 9660 | 0.020 |
Why?
|
| Life Style | 1 | 2019 | 3931 | 0.020 |
Why?
|
| Anthropometry | 1 | 2012 | 1345 | 0.020 |
Why?
|
| Maternal Mortality | 1 | 2010 | 310 | 0.020 |
Why?
|
| Public Opinion | 1 | 2011 | 484 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2014 | 2120 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2000 | 6260 | 0.020 |
Why?
|
| Skull | 1 | 1991 | 819 | 0.020 |
Why?
|
| Health Planning Guidelines | 1 | 2007 | 152 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 1997 | 1807 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 1997 | 4247 | 0.020 |
Why?
|
| Neoplasms | 1 | 2015 | 22350 | 0.020 |
Why?
|
| Energy Intake | 1 | 2014 | 2145 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2020 | 3305 | 0.020 |
Why?
|
| Patient Selection | 1 | 2018 | 4256 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2009 | 1104 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 1999 | 3266 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 1996 | 2780 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 6893 | 0.020 |
Why?
|
| Consensus | 1 | 2015 | 3207 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2009 | 1824 | 0.010 |
Why?
|
| Severity of Illness Index | 3 | 2007 | 15925 | 0.010 |
Why?
|
| Education | 1 | 2007 | 531 | 0.010 |
Why?
|
| Brain | 1 | 1991 | 27163 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 1997 | 5537 | 0.010 |
Why?
|
| Head | 1 | 2010 | 926 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6513 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2001 | 6360 | 0.010 |
Why?
|
| United States | 3 | 2023 | 72971 | 0.010 |
Why?
|
| Linear Models | 1 | 2013 | 5875 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2001 | 5389 | 0.010 |
Why?
|
| Demography | 1 | 2006 | 1641 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12790 | 0.010 |
Why?
|
| Canada | 1 | 2007 | 2127 | 0.010 |
Why?
|
| Chromosome Painting | 1 | 2001 | 26 | 0.010 |
Why?
|
| Glypicans | 1 | 2001 | 33 | 0.010 |
Why?
|
| Lymphangioma, Cystic | 1 | 2001 | 34 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 2001 | 261 | 0.010 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2005 | 575 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 2007 | 913 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2001 | 775 | 0.010 |
Why?
|
| Genomics | 1 | 2016 | 5924 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2006 | 2920 | 0.010 |
Why?
|
| Prevalence | 1 | 1997 | 15851 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2001 | 11872 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 11923 | 0.010 |
Why?
|
| Genotype | 1 | 1993 | 13035 | 0.010 |
Why?
|
| Sampling Studies | 1 | 1999 | 614 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2006 | 1806 | 0.010 |
Why?
|
| X Chromosome | 1 | 2001 | 819 | 0.010 |
Why?
|
| Apoptosis | 1 | 2013 | 9513 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1997 | 18330 | 0.010 |
Why?
|
| Personality Inventory | 1 | 2000 | 1018 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 1999 | 18063 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 7435 | 0.010 |
Why?
|
| Family Health | 1 | 2001 | 1254 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2001 | 13491 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2001 | 2342 | 0.010 |
Why?
|
| Mice | 1 | 2023 | 81912 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 12986 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2008 | 6409 | 0.010 |
Why?
|
| Syndrome | 1 | 2001 | 3271 | 0.010 |
Why?
|
| Mental Health Services | 1 | 2006 | 1733 | 0.010 |
Why?
|
| Cisplatin | 1 | 2001 | 1656 | 0.010 |
Why?
|
| Models, Biological | 1 | 2011 | 9464 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 12823 | 0.010 |
Why?
|
| Heart | 1 | 2007 | 4429 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2007 | 10092 | 0.010 |
Why?
|
| Pedigree | 1 | 2001 | 4539 | 0.010 |
Why?
|
| Yolk Sac | 1 | 1993 | 79 | 0.010 |
Why?
|
| Observer Variation | 1 | 1999 | 2616 | 0.010 |
Why?
|
| Dyspnea | 1 | 2001 | 1352 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2000 | 21178 | 0.010 |
Why?
|
| Oxygen | 1 | 2001 | 4252 | 0.000 |
Why?
|
| Pneumonia | 1 | 2001 | 2159 | 0.000 |
Why?
|
| Socioeconomic Factors | 1 | 1999 | 7848 | 0.000 |
Why?
|
| Smoking | 1 | 2001 | 9081 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2000 | 8940 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1993 | 11657 | 0.000 |
Why?
|